Precision Wealth Strategies, LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1844197 SAINT LOUIS, MO

Position in LGND

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$816,776

New position

Shares Held

2,584

first reported quarter

Ownership

0.013%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

#206

of 411 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Precision Wealth Strategies, LLC holds $2,759,900 across 3 Biotechnology names. LGND ranks #2 (29.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AUPH	Aurinia Pharmaceuticals Inc.	71,014	$1,205,107
2	LGND	Ligand Pharmaceuticals Inc This page	2,584	$816,776
3	EXEL	Exelixis, Inc.	13,564	$738,017

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$816,776	2,584	—	Shares	Sole	2026-08-10
No filing history on record for this holder in this stock.